BioPerfectus, a public listed company at Shanghai Stock Exchange (SSE:688399), is one of the leading molecular diagnostic solution providers in global in-vitro diagnostic market since 2010.
ABOUT US
One of the leading molecular diagnostic solution providers in global in-vitro diagnostic market since 2010.
PRODUCTS
Bioperfectus is key real-time PCR product supplier for Chinese disease prevention and control market.
NEWS
Company news and information of Jiangsu Bioperfectus Technology Co. Ltd..
High efficiency of workload in PCR laboratory not only requires the high throughput of the PCR & nucleic acid extraction devices, but also a good customer support team.